Home > Healthcare > Pharmaceuticals > Vaccines > BCG Vaccines Market

BCG Vaccines Market Share

Report ID: GMI9605
Published Date: May 2024
Report Format: PDF

Download Free Sample

BCG Vaccines Market Share

The BCG vaccines industry is characterized by the presence of several established and emerging players that offer a variety of products across the globe. Key players dominate the market due to their extensive product portfolios, strong distribution networks, and significant R&D investments. These companies leverage their global reach and advanced manufacturing capabilities to maintain competitive advantages.

Market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies. The market is also witnessing increased competition from emerging biotech firms focusing on innovative BCG formulations and delivery methods.

BCG Vaccines Market Companies

Prominent players operating in the BCG vaccines industry include:

AJ Biologics Sdn Bhd
BCG Vaccine Laboratory
Biomed Lublin S.A.
GSBPL
Japan BCG Laboratory
Merck & Co., Inc.
Microgen
Serum Institute of India Pvt. Ltd.
Taj Pharmaceuticals Limited
Zydus Group

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The BCG vaccines market size was valued at USD 88.3 million in 2023 and is anticipated to witness growth at 5.4% CAGR during 2024-2032, driven by the growing incidence of tuberculosis (TB).

The pediatrics age group segment held 84.9% share of the BCG vaccines industry in 2023 and will expand rapidly through 2032, as BCG vaccination is typically administered during infancy as part of the routine immunization schedule in many countries.

Asia Pacific BCG vaccines market size is predicted to grow at 5.6% CAGR during 2024-2032, owing to a significant proportion of the global TB burden.

AJ Biologics Sdn Bhd, BCG Vaccine Laboratory, Biomed Lublin S.A., GSBPL, Japan BCG Laboratory, Merck & Co., Inc, and Microgen among others.